Activated dendritic cells delivered in tissue compatible biomatrices induce in-situ anti-tumor CTL responses leading to tumor regression

Dendritic cell (DC) based anti-cancer immunotherapy is well tolerated in patients with advanced cancers. However, the clinical responses seen after adoptive DC therapy have been suboptimal. Several factors including scarce DC numbers in tumors and immunosuppressive tumor microenvironments contribute...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Verma, Vivek, Kim, Young, Lee, Min-Cheol, Lee, Jae-Tae, Cho, Sunghoon, Park, In-Kyu, Min, Jung Joon, Lee, Je Jung, Lee, Shee Eun, Rhee, Joon Haeng
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129979/
https://ncbi.nlm.nih.gov/pubmed/27223090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9529
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados